Status:
COMPLETED
Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing
Lead Sponsor:
Woman's Health University Hospital, Egypt
Conditions:
Iron Deficiency Anemia
Eligibility:
FEMALE
18-40 years
Phase:
PHASE1
PHASE2
Brief Summary
This study consisted of 60 cases. All the cases of pregnant women are 4 months to 8 months of pregnancy. The cases divided into 30 pregnant women's were given iron supplementation without health educa...
Detailed Description
The investigator will divide the participants into two groups e.g. group (A) and group (B) according to Hemoglobin level and receiving of oral supplementation for IDA accompanied with health education...
Eligibility Criteria
Inclusion
- Pregnant Women aged \>18 years
- Hemoglobin\<10g/dl
- Gestational age between 14-28 weeks
- Singleton pregnancy
- Willingness to participate and signing the informed consent form
Exclusion
- Anemia predominantly caused by factors other than IDA (e.g. anemia with untreated B12 or foliate deficiency, hemolytic anemia),
- Iron overload or disturbances in utilization of iron (e.g. hemochromatosis and haemosidrosis).
- Decompensated liver cirrhosis and active hepatitis (ALAT\>3 times upper limit of normal).
- Active acute or chronic infections (assessed by clinical judgment supplied with white Blood Cells (WBC) and C - reactive protein (CRP).
- Rheumatoid arthritis with symptoms or signs of active inflammation.
- Multiple allergies.
- Known hypersensitivity to parental iron or any recipients in the investigational drug products.
- Erythropoietin treatment within 8 weeks prior to the screening visit.
- Other iron treatment within 8 weeks prior to the screening visit.
- Planned elective surgery during the study.
- Participation in any other clinical within 3 months prior to the screening.
- Any other medical condition e.g. malignancy, uncontrolled hypertension, unstable ischemic heart disease, or uncontrolled diabetes mellitus.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2018
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT03279536
Start Date
November 1 2017
End Date
December 30 2018
Last Update
October 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women Health Hospital
Asyut, Egypt, 71111